Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis

نویسندگان

  • Sima Rafati
  • Amir Mizbani
  • Tahere Taheri
  • Farnaz Zahedifard
  • Yasaman Taslimi
  • Barbara Papadopoulou
چکیده

Parasites of the genus Leishmania are intracellular protozoa which are transmitted to their mammalian host by the bite of infected sand flies and cause a group of diseases known as Leishmaniasis. Despite attempting different vaccination strategies, no human vaccine is yet available against this disease. There is increasing evidence that presence of a small number of live parasites is necessary to maintain durable immunity, and the only way to meet this requirement is by using attenuated live vaccines [1]. The main obstacle about attenuated live strains is the risk of reversion of the organism to its virulent state. Another approach to reach this strategy is to use nonpathogenic Leishmania such as L. tarentolae. This parasite is lizard parasite and has never been found associated with any leishmaniasis in humans and is considered as non-pathogenic to humans. Previous studies have shown that L. tarentolae can be used as a live vaccine against L. donovani and elicit a protective Th1 immune response [2]. Recently, by comparative genomic analysis and expression profiles of well-characterized virulence factors such as GP63, CPB, LPG3, Amastin and A2 between pathogenic Leishmania species (e.g. L. major, L. infantum and L. braziliensis) and non pathogenic L. tarentolae revealed that only A2 is absent at the level of DNA [3]. A recombinant L. tarentolae expressing the A2 protein was generated and its potential as a live vaccine against L. infantum infection in BALB/c mice was examined [4]. The A2 expressing recombinant parasites showed higher macrophage infectivity in comparison to L. tarentolae used as a control. Immunization (i.v. and i.p.) of BALB/c mice with recombinant L. tarentolae A2 elicited a strong protective immunity against virulent L. infantum challenge, manifested by a dramatic decrease in parasite burdens in the liver and the spleen of immunized mice. IFN-g production upon antigen stimulation indicated that protection is associated with a Th1 cell-mediated immunity accompanied by reduced levels of IL-5 production (the Th2 type response). Interestingly, although IFN-g production is also induced in groups of mice immunized with wild type L. tarentolae, cytokine levels are increased in the group immunized with the recombinant L. tarentolae A2 and especially when the vaccine regimen is administered via the i.p. route [4]. In continuation of these promising results, we are expanded this idea against L. major infection as a novel vaccine regimen by including two immunogenic parasite proteins (cysteine proteinases A and B, CPA/CPB).

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis

Visceral leishmaniasis (VL) is a vector-borne disease affecting humans and domestic animals that constitutes a serious public health problem in many countries. Although many antigens have been examined so far as protein- or DNA-based vaccines, none of them conferred complete long-term protection. The use of the lizard non-pathogenic to humans Leishmania (L.) tarentolae species as a live vaccine...

متن کامل

Vaccination in Leishmaniasis: A Review Article

Leishmaniasis is caused by protozoan Leishmania parasites that are transmitted through female sandfly bites. The disease is predominantly endemic to the tropics and semi-tropics and has been reported in more than 98 countries. Due to the side effects of anti-Leishmania drugs and the emergence of drug-resistant isolates, there is currently no encouraging prospect of introducing an effective ther...

متن کامل

Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen

BACKGROUND Novel vaccination approaches are needed to prevent leishmaniasis. Live attenuated vaccines are the gold standard for protection against intracellular pathogens such as Leishmania and there have been new developments in this field. The nonpathogenic to humans lizard protozoan parasite, Leishmania (L) tarentolae, has been used effectively as a vaccine platform against visceral leishman...

متن کامل

DNA-Based Vaccine Is More Efficient than Non-Pathogenic Live Vaccine for the Prevention of HPV16 E7-Overexpressing Cancers

  Introduction: Vaccinology provides promising approaches for the control of various infectious diseases. Among different strategies, DNA vaccines offer attractive research opportunities for development of vaccines for induction of antigen-specific immunity owing to their stability, simplicity of delivery, safety and cost effectiveness. However, there is a need to increase their potency by the ...

متن کامل

Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.

Cutaneous leishmaniasis is a zoonotic, vector-borne disease causing a major health problem in several countries. No vaccine is available and there are limitations associated with the current therapeutic regimens. Immune responses to sand fly saliva have been shown to protect against Leishmania infection. A cellular immune response to PpSP15, a protein from the sand fly Phlebotomus papatasi, was...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 5  شماره 

صفحات  -

تاریخ انتشار 2011